Welcome to LookChem.com Sign In|Join Free
  • or
2H-Indazol-3-ol, 4,5,6,7-tetrahydro- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

402602-24-8

Post Buying Request

402602-24-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

402602-24-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 402602-24-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,2,6,0 and 2 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 402602-24:
(8*4)+(7*0)+(6*2)+(5*6)+(4*0)+(3*2)+(2*2)+(1*4)=88
88 % 10 = 8
So 402602-24-8 is a valid CAS Registry Number.

402602-24-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,5,6,7-Tetrahydro-2H-indazol-3-ol

1.2 Other means of identification

Product number -
Other names 2H-Indazol-3-ol,4,5,6,7-tetrahydro-(9CI)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:402602-24-8 SDS

402602-24-8Relevant academic research and scientific papers

COMPOUNDS AS GLP-1R AGONISTS

-

Paragraph 0379-0380, (2022/03/07)

The present application provides compounds that may be used as a glucagon-like peptide-1 receptors (GLP-1R) agonist, or stereoisomers, tautomers, or pharmaceutically acceptable salts of any of the foregoing. Also provided are pharmaceutical compositions containing such compounds, or stereoisomers, tautomers, or pharmaceutically acceptable salts of any of the foregoing. Methods of prepare these compounds and compositions and method of using them to treat or present a disease or a condition mediated by GLP-1R.

Synthesis of 1-Substituted 3-(Dialkylaminoalkoxy)-4,5,6,7-tetrahydro-1H-indazoles

Soga, Takeo,Niwa, Hirosuke,Shiraishi, Takanori

, p. 825 - 826 (2007/10/02)

4,5,6,7-Tetrahydro-3-indazolone was prepared by catalytic hydrogenation of 3-indazolone, and its reaction with dialkylaminoalkyl chloride was studied.In addition, a number of 1-substituted 3-(dialkylaminoalkoxy)-4,5,6,7-tetrahydro-1H-indazoles were prepar

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 402602-24-8